Standardization of Imaging Criteria for Detecting Macular Fibrosis in Neovascular Age-Related Macular Degeneration. [PDF]
Chakravarthy U +11 more
europepmc +1 more source
Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration. [PDF]
Shi J +7 more
europepmc +1 more source
Real-World Outcomes of Switching to Faricimab in Treatment-Experienced and Resistant Neovascular Age-Related Macular Degeneration: A Single-Centre Retrospective Study. [PDF]
Stewart C +7 more
europepmc +1 more source
Quantitative Optical Coherence Tomography Angiography Biomarkers Following a Switch to Brolucizumab in Neovascular Age-Related Macular Degeneration. [PDF]
Lee S, Choi J, Yu SY, Kim K.
europepmc +1 more source
Ocular pharmacokinetics of tivozanib eye drops in patients with neovascular age-related macular degeneration: comparison with phase 1 trials of oral tivozanib in solid tumors. [PDF]
Horita S +5 more
europepmc +1 more source
Japanese clinical guidelines for neovascular age-related macular degeneration. [PDF]
Iida T +7 more
europepmc +1 more source
Neovascular age-related macular degeneration complicated by large submacular hemorrhage managed with faricimab monotherapy. [PDF]
Lim J, Cho H, Ramkumar H, Adrean SD.
europepmc +1 more source
Artificial intelligence based prediction of first recurrence in neovascular age related macular degeneration with validation by 19 experts. [PDF]
Jang B +7 more
europepmc +1 more source
Correction: Artificial intelligence-based analysis of retinal fluid volume dynamics in neovascular age-related macular degeneration and association with vision and atrophy. [PDF]
Yu S +10 more
europepmc +1 more source

